View
Dec 12, 2025
Clinical & Regulatory 2025 Round-up
2025 has been a year of rapid shifts in the regulatory landscape — from evolving FDA priorities to the unique complexities of rare and orphan drug development. We’ve gathered five of our most impactful 2025 publications — each offering actionable insights and practical guidance to help navigate uncertainty, reduce risk, and maximize value in your programs. Explore the summaries below and click through to dive deeper into the full articles and whitepapers.
